Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00004915
Recruitment Status : Completed
First Posted : August 30, 2004
Last Update Posted : June 6, 2012
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Northwestern University

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : February 2000
  Study Completion Date : February 2000
  Certification/Extension First Submitted : February 16, 2011